Evaluation of Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Interventional
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To determine the accuracy of contrast enhanced ultrasound of renal masses to predict benign vs. malignant histology
conclusion of study
No
Scott Gerst, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Food and Drug Administration
07-165
NCT00671411
March 2008
November 2011
Name | Location |
---|---|
Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |